Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator among Older Patients: Does Age Matter? An Analysis of Pooled Data from 5 Clinical Trials

Circulation: Cardiovascular Quality and Outcomes

Volumn 8, Issue 2, 2015, Pages 179-186

  Hess, Paul L ^a   Al Khatib, Sana M ^a   Han, Joo Y ^b   Edwards, Rex ^a   Bardy, Gust H ^b   Bigger, J Thomas ^c   Buxton, Alfred ^d   Cappato, Riccardo ^e   Dorian, Paul ^f   Hallstrom, Al ^b   Kadish, Alan H ^g   Kudenchuk, Peter J ^b   Lee, Kerry L ^a   Mark, Daniel B ^a   Moss, Arthur J ^h   Steinman, Richard ^c   Inoue, Lurdes Y T ^b   Sanders, Gillian ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Columbia University ^*  (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e IRCCS POLICLINICO SAN DONATO   (Italy)

^f UNIVERSITY OF TORONTO   (Canada)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Aging; defibrillators; implantable; meta analysis

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; GROUPS BY AGE; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS; MULTICENTER STUDY (TOPIC); NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECIPIENT; SAMPLE SIZE; SUDDEN CARDIAC DEATH; SURVIVAL; SYSTEMATIC REVIEW; TACHYCARDIA; ADVERSE EFFECTS; AGE; AGED; BAYES THEOREM; CARDIOMYOPATHIES; CARDIOVERSION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL (TOPIC); COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEVICES; FEMALE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

AGE FACTORS; AGED; BAYES THEOREM; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; CLINICAL TRIALS AS TOPIC; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT READMISSION; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84932197798     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.114.001306     Document Type: Article

References (35)

1. Moss AJ, Hall J, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted cardioverter-defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996; 335:1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G; Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890. doi: 10.1056/NEJM199912163412503.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. doi: 10.1056/NEJMoa013474.
4. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158. doi: 10.1056/NEJMoa033088.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. doi: 10.1056/NEJMoa043399.
6. Epstein AE, Kay GN, Plumb VJ, McElderry HT, Doppalapudi H, Yamada T, Shafiroff J, Syed ZA, Shkurovich S; ACT Investigators. Implantable cardioverter-defibrillator prescription in the elderly. Heart Rhythm. 2009;6:1136-1143. doi: 10.1016/j.hrthm.2009.04.010.
7. Older Americans 2010: Key Indicators of Well-Being. Federal Interagency Forum on Aging-Related Statistics. 2010:1-156.
8. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, Kapa S, Kremers MS, Lindsay BD, Stevenson LW. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm. 2013;10:e11-e58. doi: 10.1016/j.hrthm.2013.01.008.
9. Lee KL, Hafley G, Fisher JD, Gold MR, Prystowsky EN, Talajic M, Josephson ME, Packer DL, Buxton AE; Multicenter Unsustained Tachycardia Trial Investigators. Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation. 2002;106:233-238.
10. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337:1576-1583.
11. Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748-754.
12. Bigger JT, Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 1997; 332:1569-1575.
13. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ; DINAMIT Investigators. Prophylactic use of implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488. doi: 10.1056/NEJMoa041489.
14. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350-e408. doi: 10.1161/CIRCUALTIONAHA.108.189742.
15. Ibrahim JG, Chen MH, Sinha D. Bayesian Survival Analysis. New York, NY: Springer-Verlag; 2001.
16. Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res. 2001;10:277-303.
17. Gelman A, Carlin JB, Stern HS, Dunson DB, Vehtari A, Rubin DB. Bayesian Analysis. 3rd ed. Boca Raton, FL: Taylor & Francis group, LLC; 2014.
18. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBugs-A Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325-337.
19. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ; MADIT-II Research Group. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007;18:833-838. doi: 10.1111/j.1540-8167.2007.00857.x.
20. Santangeli P, Di Biase L, Dello Russo A, Casella M, Bartoletti S, Santarelli P, Pelargonio G, Natale A. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153:592-599. doi: 10.7326/0003-4819-153-9-201011020-00009.
21. Kong MH, Al-Khatib SM, Sanders GD, Hasselblad V, Peterson ED. Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis. Cardiol J. 2011;18:503-514.
22. Hernandez AF, Fonarow GC, Hammill BG, Al-Khatib SM, Yancy CW, O'Connor CM, Schulman KA, Peterson ED, Curtis LH. Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail. 2010;3:7-13. doi: 10.1161/CIRCHEARTFAILURE.109.884395.
23. Yung D, Birnie D, Dorian P, Healey JS, Simpson CS, Crystal E, Krahn AD, Khaykin Y, Cameron D, Chen Z, Lee DS. Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation. 2013;127:2383-2392. doi: 10.1161/CIRCULATIONAHA.113.001442.
24. Brullmann S, Dichtl W, Paoli U, Haegeli L, Schmied C, Steffel J, Brunckhorst C, Hintringer F, Seifert B, Duru F, Wolber T. Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged ?75 years versus those. Am J Cardiol. 2011; 109: 712-717
25. Krahn AD, Connolly SJ, Roberts RS, Gent M; ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J. 2004;147:837-840. doi: 10.1016/j.ahj.2003.12.017.
26. Fumagalli S, Valsecchi S, Boriani G, Gasparini M, Landolina M, Lunati M, Padeletti M, Tronconi F, Marchionni N, Padeletti L. Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (65, 65-74 and 75 years) (from the InSync/InSync ICD Italian Registry). Am J Cardiol. 2011; 107: 1510-1516. doi: 10.1016/j.amjcard.2011.01.031
27. Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122:585-596. doi: 10.1161/CIRCULATIONAHA.109.934471.
28. Fahy GJ, Sgarbossa EB, Tchou PJ, Pinski SL. Hospital readmission in patients treated with tiered-therapy implantable defibrillators. Circulation. 1996;94:1350-1356.
29. Korte T, Jung W, Ostermann G, Wolpert C, Spehl S, Esmailzadeh B, Lüderitz B. Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study. Eur Heart J. 2000;21:1186-1191. doi: 10.1053/euhj.1999.2044.
30. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD; Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group. Longterm clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760-3765. doi: 10.1161/01.CIR.0000150390.04704.B7.
31. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS; Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation. 2006;113:2810-2817. doi: 10.1161/CIRCULATIONAHA.105.577262.
32. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverterdefibrillators. J Am Coll Cardiol. 2004;43:2293-2299. doi: 10.1016/j. jacc.2004.03.031.
33. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML; MADIT-II Investigators. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008;51:288-296. doi: 10.1016/j.jacc.2007.08.058.
34. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jr., Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death). J Am Coll Cardiol. 2006; 48:e247-346.
35. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, Cygankiewicz I, Zareba W; Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation. 2010;122:1265-1271. doi: 10.1161/CIRCULATIONAHA.110.940148.